Home › Epstein-Barr Virus Infections
Pag-aaral pangklinika para sa Epstein-Barr Virus Infections na nagre-recruit sa U.S.
16 pag-aaral para sa Epstein-Barr Virus Infections ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03258567Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 29 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06908096Donor-Derived Viral Specific T-cells (VSTs)
Nagre-recruitPhase 1/2
4 Weeks · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
Nagre-recruitPhase 2
2 Days · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02532452A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06789159A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Set 2, 2026 · NCT03394365Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05389423A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Nagre-recruitPhase 1
3 Months – 26 Years · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT06926894Genetic Studies of Chronic Active Epstein-Barr Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 1 hanggang 120 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT00032513EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Nagre-recruitPhase 1
Lahat ng edad · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT04664179Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06682442TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Nagre-recruitPhase 1
Lahat ng edad · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT04013802R-MVST Cells for Treatment of Viral Infections
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT05183490Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Nagre-recruitPhase 1/2
1 Month – 65 Years · Lahat ng kasarian · Na-update Ago 14, 2025 · NCT06909110EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Nagre-recruitPhase 2
1 Month – 79 Years · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT03266653Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.